Antiretroviral News and Research

RSS

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

CONRAD and the South African Government's Technology Innovation Agency (TIA) today announced a license agreement that grants TIA the rights to manufacture and distribute Tenofovir1% gel in Africa.

15 Jun 2011

U.N. High Level Meeting on AIDS declaration sets new targets in fight against disease

World leaders on Friday at the U.N. High Level Meeting on AIDS adopted by consensus a declaration stating that HIV is "an unprecedented human catastrophe" and set new targets in the fight against the disease, the Associated Press/Forbes reports.

14 Jun 2011

UNAIDS, PEPFAR announce campaign to eliminate MTCT of HIV by 2015

A team led by UNAIDS and PEPFAR on Thursday at the U.N. High Level Meeting on AIDS announced a plan to virtually eliminate mother-to-child transmission of HIV by 2015 by "ensuring that all women, especially pregnant ones, have access to quality life-saving HIV prevention and treatment services - for themselves and their children," BBC News reports.

13 Jun 2011

S. African government program reduced MTCT HIV transmission rate to 3.5%, study shows

The South African government's program to prevent mother-to-child transmission (PMTCT) of HIV has reduced the rate of virus transmission to about 3.5 percent, "potentially sparing some 67,000 babies from HIV infection," according to research presented on Wednesday by the Medical Research Council at the 5th South African AIDS Conference in Durban, Health-e/allAfrica.com reports.

13 Jun 2011

Global initiative to prevent HIV in babies

World leaders met to decide on the launch of a global plan with the goal of ensuring that every baby is born HIV-free by 2015 and that their mothers with the HIV virus live to raise them.

9 Jun 2011

Make antiretroviral therapy 'cornerstone' of HIV prevention

Ahead of the U.N. High Level Meeting on AIDS, AVAC: Global Advocacy for HIV Prevention and multiple signatories in a statement call on governments, advocates and researchers to act on the evidence from HPTN 052 and make antiretroviral therapy a cornerstone of the set of proven strategies we have to prevent and treat HIV.

9 Jun 2011

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

Hepatitis C virus (HCV)-associated liver disease continues to be the most common indication for liver transplantation (LT) in the United States accounting for nearly 50% of all liver transplants. Recurrence is universal in patients viremic at the time of transplantation with histological hepatitis developing in the majority of patients. Although the natural history of recurrent HCV is difficult to predict, it is widely accepted that cirrhosis from recurrent HCV occurs in up to 30% of patients within five years of transplantation.

8 Jun 2011

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

As world leaders meet this week to review progress and chart the future course of the global AIDS response at the 2011 UN General Assembly High-Level Meeting on AIDS in New York, the International AIDS Society (IAS) calls on leaders to ensure the inclusion of HIV cure research and its global strategy into the international HIV agenda and in all discussions, political decisions and funding strategies.

8 Jun 2011

International coalition launches common platform to end AIDS epidemic

An international coalition of scientists and activists today launched a common platform for ending the AIDS epidemic. Thirty years into the epidemic, as world leaders come together at the United Nations to recommit to a global AIDS response, the broad-based international coalition issued a statement calling for world leaders to support a rational, evidence-based approach to responding to AIDS.

8 Jun 2011

Focus on getting more people on antiretroviral therapy as AIDS turns 30

Sunday marked the 30th anniversary of the first published report of the disease that came to be known as AIDS, the Los Angeles Times reports. Though the "promise" of a vaccine "has not materialized," "[s]ome progress has been made on other fronts," the newspaper writes.

7 Jun 2011

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

In data presented at The American Society of Clinical Oncology (ASCO) Annual Meeting, cancer researchers found that the brain tumor vaccine HSPPC-96 for treating recurrent gliobastoma (GBM) has a favorable safety profile and extends survival by two to three times more than the current median survival rate.

4 Jun 2011

Scientists demonstrate why B cells exposed to chronic HIV shut down, how they can be reactivated

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have demonstrated why certain immune cells chronically exposed to HIV shut down, and how they can be reactivated.

4 Jun 2011

Study assesses public's willingness to consider pre-exposure prophylaxis for HIV prevention

In a recent clinical trial, non-HIV-infected individuals who used the antiretroviral drug Truvada on a daily basis cut their risk of becoming infected with HIV by 44 percent.

4 Jun 2011

FSU assistant professor unlocks mysteries of KSHV infection

In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal the cancerous skin lesions from his co-workers in the 1993 movie "Philadelphia."

4 Jun 2011

Mouse virus not responsible for Chronic Fatigue Syndrome, new study finds

Two years ago, a widely publicized scientific report plucked an old mouse virus out of obscurity and held it up as a possible cause of Chronic Fatigue Syndrome. According to a new study published today by a group of researchers in California, Wisconsin and Illinois, that report was wrong.

1 Jun 2011

UNAIDS Director says Pope's comments on condoms open dialogue for HIV prevention

UNAIDS Executive Director Michel Sidibe on Saturday "told a Vatican conference [Pope Benedict XVI] had opened the door to greater dialogue with his groundbreaking comments on condoms and HIV prevention - even as Vatican officials stressed abstinence and marital fidelity as the best prevention," the Associated Press reports.

1 Jun 2011

NIH scientists discuss expanded HIV testing and new prevention tools

In the 30 years since the first reported cases of a mysterious illness now known as AIDS, researchers have made extraordinary advances in understanding, treating and preventing the disease.

1 Jun 2011

State roundup: Texas budget cuts; Florida's 'F' in kids' teeth; new insurance programs for Conn., Maine

Texas lawmakers adopted a state budget Saturday night ... Facing a massive revenue shortfall, lawmakers crafted the $172 billion budget by making cuts and using deferrals rather than raising taxes or dipping into the $10 billion reserve fund.

1 Jun 2011

Chronic fatigue syndrome and mouse virus – no association

An earlier study published in 2009 had claimed that a mouse virus was the cause of chronic fatigue syndrome. New evidence suggests that this assumption is wrong. According to latest evidence the earlier study findings were likely based on contaminated lab samples, US researchers said Tuesday.

1 Jun 2011

AIDS epidemic turns 30

It is 30 years since the beginning of the AIDS epidemic. It was fatal then but has now become a treatable, if still incurable, chronic illness. AIDS therapy now has tools that prolong the lives of people infected with the virus and prevent others from acquiring it. They range from antiretroviral therapy (ART), to circumcision and campaigns to reduce promiscuity. On the horizon are gels and pills that protect against infection during intercourse. Even the outlook for an AIDS vaccine is no longer as bleak as it used to be.

31 May 2011

Antiretroviral News and Research

TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa

U.N. High Level Meeting on AIDS declaration sets new targets in fight against disease

UNAIDS, PEPFAR announce campaign to eliminate MTCT of HIV by 2015

S. African government program reduced MTCT HIV transmission rate to 3.5%, study shows

Global initiative to prevent HIV in babies

Make antiretroviral therapy 'cornerstone' of HIV prevention

Hepatitis C virus (HCV)-associated liver disease after liver transplantation

IAS calls on leaders to ensure inclusion of HIV cure research into international AIDS agenda

International coalition launches common platform to end AIDS epidemic

Focus on getting more people on antiretroviral therapy as AIDS turns 30

Results from HSPPC-96 Phase 2 study against recurrent gliobastoma presented at ASCO 2011

Scientists demonstrate why B cells exposed to chronic HIV shut down, how they can be reactivated

Study assesses public's willingness to consider pre-exposure prophylaxis for HIV prevention

FSU assistant professor unlocks mysteries of KSHV infection

Mouse virus not responsible for Chronic Fatigue Syndrome, new study finds

UNAIDS Director says Pope's comments on condoms open dialogue for HIV prevention

NIH scientists discuss expanded HIV testing and new prevention tools

State roundup: Texas budget cuts; Florida's 'F' in kids' teeth; new insurance programs for Conn., Maine

Chronic fatigue syndrome and mouse virus – no association

AIDS epidemic turns 30

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News